The most recent research on the use of nutraceuticals in the context of CVD prevention and therapy is excitingly updated in this book. The book “Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives“ is truly enlightening for cardiologists, and researchers working in the field of cardiovascular pharmacology and helps the common man since this book deals with nutraceuticals that are commonly available for consumption in homes.
The first chapter of the book “Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives“, which has ten chapters overall, provides an overview of cardiovascular disease (CVD) and its pathophysiological mechanisms. The second chapter provides information on congestive heart failure and pharmacotherapy, while the third chapter discusses nutrition and antioxidant use in preventing vascular inflammation. The uses, benefits, and drawbacks of numerous rodent and non-rodent animal models for studying CVD are detailed in Chapter 4. In contrast, chapter 5 describes 21st-century CRISPR-cas9 technology and its uses in CVD.
The significance of Indian Ayurvedic techniques on the cardiovascular system, etiopathogenesis, and treatment approaches are discussed in Chapter 6. Nutraceuticals are shown in Chapter 7 as possible tools to protect the human race against CVD. The therapeutic potential and mechanism of action of Biochanin-A against hypertension are discussed in Chapter 8. The focus of Chapter 9 is on Zingiberene's ability to treat obesity cardiomyopathy. Chapter 10 concludes with a discussion of how Betaine reduces the formation of matrix-metalloproteinase and pro-inflammatory cytokines, which both contribute to myocardial infarction improvement.
About the editors:
Dr. V. V. Sathibabu Uddandrao is currently working as an Assistant Professor of Biochemistry at K.S. Rangasamy College of Arts and Science (Autonomous), Tiruchengode, Tamilnadu, India. He received his Ph.D. degree from Periyar University, Tamilnadu, India. He has received a junior research fellowship from a DST-SERB-funded project and has also been awarded a senior research fellowship (ICMR-SRF) from the Indian Council of Medical Research (ICMR), Government of India. He is currently working on metabolic disorders (Diabetes, Obesity, Cardiovascular disorders) and nutraceuticals. He has published 40 research articles in reputed international peer-reviewed journals with high impact factors and 2 book chapters in standard book editions, published by international publishers. He received the “National Level Best Academic Researcher” award in the year 2019 from Dr. Kalam Educational Trust, Tamilnadu. He is also currently acting as an author and reviewer and editing a few books.
Dr. P. Brahmanaidu is currently working as DST-Inspire faculty in ICMR- National Animal Resource Facility for Biomedical Research, Hyderabad, India. He received M.Sc., and Ph.D., degrees from Periyar University, Tamilnadu, India and Jawaharlal Nehru Technological University Hyderabad (JNTUH), Hyderabad, India, respectively. He did a PG diploma in patent law from Nalsar University, Hyderabad, India and underwent lab animal supervisor training from ICMR-National Institute of Nutrition (NIN), Hyderabad, India. He is an expert in cardiovascular disorders, obesity and its treatment with natural products. He has received funded projects from the DST-INSPIRE, Government of India. He has published 31 research articles and 4 review articles in reputed international journals. He also published 5 book chapters in standard book editions. He is currently serving as a reviewer and editing a few books.
Keywords:
Cardiovascular disorders 11 Phytochemicals, Nutraceuticals 12 Hypertension, Natural products 13 Obesity-cardiomyopathy, Medicinal plants 14 Myocardial Infarction, Therapeutics 15 Oxidative stress, Heart Failure 16 Antioxidants, Cardiomyopathy 17 Rodent and Non-Rodent Animal Models, Inflammation 18 Pharmacotherapy, Crispr-Cas9 Technologies 19 Diet, Ayurveda 20 Plants and herbs.
For more information please visit: https://bit.ly/3g6SJPE